News FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs September 13, 2019Ken Alltucker, USA TODAYComments Off on FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs The FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled